寶島科 5312.TW Value Analysis

TW StockBiotech. & Medical
(No presentation for 5312)

5312 Value Score

3

24

15

Good Growth
  • AI analysis rates 5312  with a higher value score of 4.
  • It is mainly due to  stable revenue growth, along with stable operating cash flow.
  • Over the past 3 months, 5312 has maintained an average value rating of 4.3, close to the rating of 4.4 over the past 3 years, indicating stable enterprise value.
  • Compared to all stocks in the Biotech. & Medical sector, 5312 has a medium value rating.

5312 Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/03/14 (Weekly Update)

5312 Financial Forecast

Unit : TWD

Update to 2025/5/9 (Quarterly Update)

5312 Earnings Table

Unit : TWD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
1.59
-3.6%
-
980.15M
0.1%
-
9.7%
2024Q3
2.49
26.4%
-
1.01B
2.6%
-
14.8%
2024Q1
2.37
20.9%
-
1.02B
5.3%
-
13.9%
2023Q4
1.65
211.3%
-
979.12M
13%
-
10.1%

Update to 2025/5/11 (Quarterly Update)

5312 Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

5312 Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of 5312 from 2007/01 till Now

264.62%
Cumulative Return
7.50%
Annual Return
19.25%
Volatility
0.39
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 4)

5312SectorTW Overall Market
Wining Rate100%46%53%
Avg Return52%21.1%45.4%
Avg Profit52%72.2%102.9%
Avg Loss--22.4%-20.3%
Avg Risk-Reward Ratio-322.8%505.8%

Update to 2025/5/12 (Daily Update)

Top 10 High Relevance to 5312 Value Score